Raymond James Financial Services Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-15,180
| Closed | -$508K | – | 3248 |
|
|
2021
Q2 | $508K | Sell |
15,180
-71
| -0.5% | -$2.38K | ﹤0.01% | 2353 |
|
|
2021
Q1 | $314K | Buy |
15,251
+71
| +0.5% | +$1.46K | ﹤0.01% | 2594 |
|
|
2020
Q4 | $266K | Sell |
15,180
-20
| -0.1% | -$350 | ﹤0.01% | 2534 |
|
|
2020
Q3 | $225K | Sell |
15,200
-200
| -1% | -$2.96K | ﹤0.01% | 2456 |
|
|
2020
Q2 | $200K | Sell |
15,400
-1,586
| -9% | -$20.6K | ﹤0.01% | 2488 |
|
|
2020
Q1 | $28K | Buy |
16,986
+46
| +0.3% | +$76 | ﹤0.01% | 2331 |
|
|
2019
Q4 | $38K | Hold |
16,940
| – | – | ﹤0.01% | 2764 |
|
|
2019
Q3 | $36K | Hold |
16,940
| – | – | ﹤0.01% | 2707 |
|
|
2019
Q2 | $45K | Buy |
+16,940
| New | +$45K | ﹤0.01% | 2739 |
|
|
2019
Q1 | – | Sell |
-1,942
| Closed | -$6K | – | 2768 |
|
|
2018
Q4 | $6K | Sell |
1,942
-5
| -0.3% | -$15 | ﹤0.01% | 2535 |
|
|
2018
Q3 | $13K | Buy |
1,947
+155
| +9% | +$1.04K | ﹤0.01% | 2759 |
|
|
2018
Q2 | $14K | Sell |
1,792
-67
| -4% | -$523 | ﹤0.01% | 2714 |
|
|
2018
Q1 | $65K | Hold |
1,859
| – | – | ﹤0.01% | 2419 |
|
|
2017
Q4 | $79K | Buy |
1,859
+67
| +4% | +$2.85K | ﹤0.01% | 2387 |
|
|
2017
Q3 | $77K | Hold |
1,792
| – | – | ﹤0.01% | 2411 |
|
|
2017
Q2 | $66K | Sell |
1,792
-134
| -7% | -$4.94K | ﹤0.01% | 2373 |
|
|
2017
Q1 | $104K | Buy |
1,926
+400
| +26% | +$21.6K | ﹤0.01% | 2249 |
|
|
2016
Q4 | $81K | Sell |
1,526
-347
| -19% | -$18.4K | ﹤0.01% | 2200 |
|
|
2016
Q3 | $114K | Buy |
1,873
+656
| +54% | +$39.9K | ﹤0.01% | 2128 |
|
|
2016
Q2 | $80K | Buy |
+1,217
| New | +$80K | ﹤0.01% | 2116 |
|